Login

Paul Grint Discusses AmpliPhi Biosciences - Paul Grint, CEO, AmpliPhi Biosciences Corp 00:00:00

Share On Facebook Share On Twitter

Paul Grint Discusses AmpliPhi Biosciences

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Invests in entrepreneures that are disrupting the consumer space|Assia Grazioli,Co-founder and Partner,Muse Capital
00:10:00
Basler AYV 2022: Elevating Vision Solutions Beyond Products | Dr. Dietmar Ley - CEO of Basler AG
00:10:00
G Mining Ventures Will Mine Gold in 2024 Using a Proven Track Record of Mine Building Success | Louis-Pierre Gignac, CEO, G-MINING Sarl (IE)
00:10:00
Leaders Discuss Solutions for the New Decade | Keiichi Yoshii, CEO , Daiwa house industry co.
00:10:00
Tribeca Resources Focuses on Major IOCG Deposits in Northern Chile
00:10:00
Basil Karampelas discusses ClearVue Technologies Ltd.'s vision and progress in an interview with The Market Herald.
00:10:00
Innovative Pharmaceuticals: Progress and Prospects Revealed by Industry Leader| Dr Maciej Wieczorek, CEO,Celon Pharma SA.
00:10:00
Hakeem Belo-Osagie, Chairman of Emerging Markets Telecommunications Services Ltd. and Founder of Premium Telecommunications Holdings.
00:10:00
Gold 79 Mines: Advancing Southwest U.S. Gold Exploration
00:10:00
Pandemic Perspectives: Cargojet CEO's Supply Chain Insights | Dr. Ajay K. Virmani - CEO of Cargojet
00:10:00
Orion Minerals' Strategic Development Plans Unveiled at One-to-One Mining Conference in Cape Town
00:10:00
Gula Tech Adventures are cyber security industry veterans helping the next generation with funding and our experience|Cyndi Gula,Managing Partner,Gula Tech Adventures

© 2017 - Neuhu+